Matt Miksic
Stock Analyst at Barclays
(3.91)
# 1,865
Out of 5,010 analysts
807
Total ratings
54.9%
Success rate
3.7%
Average return
Main Sectors:
Stocks Rated by Matt Miksic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Reiterated: Buy | $96 → $89 | $43.88 | +102.83% | 50 | May 28, 2026 | |
| PODD Insulet | Reiterated: Sell | $198 | $132.84 | +49.05% | 20 | May 28, 2026 | |
| DXCM DexCom | Rated: Sell | $67 → $64 | $86.64 | -26.13% | 22 | May 18, 2026 | |
| AVR Anteris Technologies Global | Reiterated: Buy | $17 → $18 | $7.59 | +137.15% | 6 | May 15, 2026 | |
| HUMA Humacyte | Rated: Buy | $1.5 | $0.5327 | +181.58% | 4 | May 13, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Hold | $255 | $267.57 | -4.70% | 93 | May 13, 2026 | |
| OBIO Orchestra BioMed Holdings | Rated: Buy | $12 → $13 | $6.08 | +113.82% | 7 | May 13, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $202 → $204 | $181.97 | +12.11% | 23 | May 11, 2026 | |
| GMED Globus Medical | Reiterated: Buy | $123 | $75.69 | +62.50% | 49 | May 11, 2026 | |
| SENS Senseonics Holdings | Reiterated: Buy | $31 | $10.05 | +208.46% | 7 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $55 | $16.57 | +231.93% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $19 | $14.22 | +33.61% | 26 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $73 → $76 | $76.99 | -1.29% | 21 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $24 | $10.37 | +131.44% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 74.63 → CHF 64.68 | CHF 54.40 | +18.90% | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $27 | $23.48 | +14.99% | 41 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $469 → $394 | $278.77 | +41.34% | 48 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $17.14 | +16.69% | 18 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $87 → $78 | $66.46 | +17.36% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $100 → $94 | $91.34 | +2.91% | 40 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 → $110 | $88.08 | +24.89% | 58 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $712 → $651 | $412.18 | +57.94% | 19 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $144 → $143 | $100.95 | +41.65% | 50 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 → $120 | $87.09 | +37.79% | 68 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $20.04 | +29.74% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 | $56.63 | +81.88% | 6 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.39 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $722 → $418 | $144.01 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $13 | $0.09 | n/a | 2 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $28 | $18.60 | n/a | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $67 | $8.98 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $84.97 | n/a | 3 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $79 → $87 | $16.64 | n/a | 25 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $23.33 | n/a | 1 | Sep 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $9 | $4.67 | n/a | 1 | Dec 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $2.02 | n/a | 1 | Oct 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37 | $26.95 | n/a | 1 | Nov 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 | $9.54 | n/a | 2 | Oct 10, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $33 → $36 | $46.69 | n/a | 2 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $9.75 | n/a | 3 | Mar 14, 2013 |
Boston Scientific
May 28, 2026
Reiterated: Buy
Price Target: $96 → $89
Current: $43.88
Upside: +102.83%
Insulet
May 28, 2026
Reiterated: Sell
Price Target: $198
Current: $132.84
Upside: +49.05%
DexCom
May 18, 2026
Rated: Sell
Price Target: $67 → $64
Current: $86.64
Upside: -26.13%
Anteris Technologies Global
May 15, 2026
Reiterated: Buy
Price Target: $17 → $18
Current: $7.59
Upside: +137.15%
Humacyte
May 13, 2026
Rated: Buy
Price Target: $1.5
Current: $0.5327
Upside: +181.58%
Johnson & Johnson
May 13, 2026
Reiterated: Hold
Price Target: $255
Current: $267.57
Upside: -4.70%
Orchestra BioMed Holdings
May 13, 2026
Rated: Buy
Price Target: $12 → $13
Current: $6.08
Upside: +113.82%
Becton, Dickinson and Company
May 11, 2026
Rated: Buy
Price Target: $202 → $204
Current: $181.97
Upside: +12.11%
Globus Medical
May 11, 2026
Reiterated: Buy
Price Target: $123
Current: $75.69
Upside: +62.50%
Senseonics Holdings
May 11, 2026
Reiterated: Buy
Price Target: $31
Current: $10.05
Upside: +208.46%
May 8, 2026
Reiterated: Buy
Price Target: $56 → $55
Current: $16.57
Upside: +231.93%
May 7, 2026
Reiterated: Buy
Price Target: $21 → $19
Current: $14.22
Upside: +33.61%
May 7, 2026
Reiterated: Hold
Price Target: $73 → $76
Current: $76.99
Upside: -1.29%
May 6, 2026
Reiterated: Buy
Price Target: $27 → $24
Current: $10.37
Upside: +131.44%
May 6, 2026
Reiterated: Hold
Price Target: CHF 74.63 → CHF 64.68
Current: CHF 54.40
Upside: +18.90%
May 4, 2026
Reiterated: Buy
Price Target: $25 → $27
Current: $23.48
Upside: +14.99%
May 1, 2026
Reiterated: Buy
Price Target: $469 → $394
Current: $278.77
Upside: +41.34%
Apr 30, 2026
Reiterated: Hold
Price Target: $20
Current: $17.14
Upside: +16.69%
Apr 30, 2026
Reiterated: Hold
Price Target: $87 → $78
Current: $66.46
Upside: +17.36%
Apr 29, 2026
Reiterated: Sell
Price Target: $100 → $94
Current: $91.34
Upside: +2.91%
Apr 24, 2026
Reiterated: Buy
Price Target: $104 → $110
Current: $88.08
Upside: +24.89%
Apr 23, 2026
Rated: Buy
Price Target: $712 → $651
Current: $412.18
Upside: +57.94%
Apr 20, 2026
Rated: Buy
Price Target: $144 → $143
Current: $100.95
Upside: +41.65%
Apr 1, 2026
Reiterated: Buy
Price Target: $118 → $120
Current: $87.09
Upside: +37.79%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $20.04
Upside: +29.74%
Mar 24, 2026
Reiterated: Buy
Price Target: $103
Current: $56.63
Upside: +81.88%
May 11, 2022
Reiterated: Buy
Price Target: $25
Current: $1.39
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $722 → $418
Current: $144.01
Upside: n/a
Mar 4, 2022
Reiterated: Buy
Price Target: $16 → $13
Current: $0.09
Upside: n/a
Mar 2, 2022
Reiterated: Buy
Price Target: $31 → $28
Current: $18.60
Upside: n/a
Mar 1, 2022
Reiterated: Buy
Price Target: $74 → $67
Current: $8.98
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $100
Current: $84.97
Upside: n/a
Nov 3, 2021
Reiterated: Buy
Price Target: $79 → $87
Current: $16.64
Upside: n/a
Sep 30, 2021
Initiated Coverage: Buy
Price Target: $55
Current: $23.33
Upside: n/a
Dec 12, 2016
Initiated Coverage: Sell
Price Target: $9
Current: $4.67
Upside: n/a
Oct 31, 2016
Initiated Coverage: Buy
Price Target: $21
Current: $2.02
Upside: n/a
Nov 3, 2014
Reiterated: Hold
Price Target: $37
Current: $26.95
Upside: n/a
Oct 10, 2013
Downgraded: Hold
Price Target: $30
Current: $9.54
Upside: n/a
Jul 24, 2013
Rated: Hold
Price Target: $33 → $36
Current: $46.69
Upside: n/a
Mar 14, 2013
Reiterated: Hold
Price Target: $43
Current: $9.75
Upside: n/a